Inter & Co, Inc. has successfully completed its sales facility for the Level II Sponsored BDR Program, a significant event for the company and its stakeholders. The completion of this facility involved the sale of over 12 million shares, highlighting the company’s strategic efforts to enhance its capital structure and shareholder value.
This development is particularly relevant in the context of the commercial banking industry, as it showcases the innovative financing mechanisms banks are employing to adapt to changing market conditions. The completion of the sales facility may prompt other banks to consider similar strategies to optimize their capital raising efforts.
Background
Inter & Co, Inc. operates in the commercial banking sector, classified under the SIC code 6029 (Commercial Banks, NEC). The company is publicly traded on the Nasdaq under the ticker symbol INTR. Inter & Co has been active in the market, with several recent filings, including multiple 6-K forms leading up to this announcement.
What the Filing Says
According to the filing dated November 16, 2026, "All Class A Common Shares subject to the Sales Facility were sold on Nasdaq between October 21, 2026 and November 9, 2026, totaling 12,281,668 Class A Common Shares." The average price obtained was US$ 5.0201 per share. The funds generated from these sales will be converted into Brazilian reais, with a final amount payable to each holder of Level II Sponsored BDRs of R$ 26.793152419.
Impact
This completion of the sales facility may affect various stakeholders, including shareholders of Inter & Co, who will receive payments based on their holdings in the Level II Sponsored BDRs. Additionally, it may influence other banks in the commercial banking sector as they evaluate their own capital-raising strategies in light of this successful execution.
What's Next
The filing indicates that the funds referring to the final amount will be sent by Banco Bradesco S.A. to the Central Depositary of B3 on November 18, 2026. The company has committed to keeping the market and its shareholders informed about the next steps in the discontinuation of the Level II Sponsored BDR Program.
Read Next
Chen Minlei Reports Significant Stock Transactions at Kingstone
Orlando Steven J sells 702 shares of Molina Healthcare
Rothblatt Executes Stock Transactions as CEO of United Therapeutics
AMASS BRANDS Major Shareholder Sells Significant Stock
CEO Lauber David Taylor sells over 19,000 Shift4 shares
Rithm Perpetual Life Residential Trust Reports NAV Per Share





